DOCS icon

Doximity

72.83 USD
+1.80
2.53%
At close Updated Sep 15, 1:04 PM EDT
1 day
2.53%
5 days
4.39%
1 month
11.82%
3 months
30.15%
6 months
16.66%
Year to date
35.98%
1 year
84.66%
5 years
37.42%
10 years
37.42%
 

About: Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.

Employees: 830

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 10 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

2% more capital invested

Capital invested by funds: $7.29B [Q1] → $7.46B (+$175M) [Q2]

2% more call options, than puts

Call options by funds: $110M | Put options by funds: $108M

4% less funds holding

Funds holding: 485 [Q1] → 467 (-18) [Q2]

5.19% less ownership

Funds ownership: 94.03% [Q1] → 88.84% (-5.19%) [Q2]

11% less first-time investments, than exits

New positions opened: 95 | Existing positions closed: 107

15% less repeat investments, than reductions

Existing positions increased: 149 | Existing positions reduced: 176

60% less funds holding in top 10

Funds holding in top 10: 5 [Q1] → 2 (-3) [Q2]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$59
19% downside
Avg. target
$69
6% downside
High target
$80
10% upside

10 analyst ratings

positive
60%
neutral
40%
negative
0%
Baird
Vikram Kesavabhotla
$80
Outperform
Maintained
11 Sep 2025
Piper Sandler
Jessica Tassan
$69
Overweight
Maintained
11 Aug 2025
Canaccord Genuity
Richard Close
$59
Hold
Maintained
8 Aug 2025
Raymond James
Brian Peterson
$75
Outperform
Maintained
8 Aug 2025
Wells Fargo
Stan Berenshteyn
$65
Equal-Weight
Maintained
8 Aug 2025

Financial journalist opinion

Negative
Zacks Investment Research
2 days ago
Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know
Doximity (DOCS) closed at $71.03 in the latest trading session, marking a +1.1% move from the prior day.
Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know
Neutral
Business Wire
19 days ago
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors. Investors who have continuously held Doximity shares since before June 24, 2021, may have legal rights and are encouraged to contact the firm to learn more: https://www.johnsonfistel.com/investigations/doximity-inc-2 On May 13, 2025, the C.
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
Positive
Zacks Investment Research
1 month ago
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Positive
Benzinga
1 month ago
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Neutral
Seeking Alpha
1 month ago
Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS ) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Perry Scott Gold - Head of Investor Relations Conference Call Participants Allen Charles Lutz - BofA Securities, Research Division Brian Christopher Peterson - Raymond James & Associates, Inc., Research Division Brian Gil Tanquilut - Jefferies LLC, Research Division Craig Matthew Hettenbach - Morgan Stanley, Research Division David Michael Larsen - BTIG, LLC, Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division Michael Aaron Cherny - Leerink Partners LLC, Research Division Ryan Michael MacDonald - Needham & Company, LLC, Research Division Ryan Scott Daniels - William Blair & Company L.L.C.
Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
Neutral
The Motley Fool
1 month ago
Doximity (DOCS) Q1 Revenue Rises 15%
Doximity (DOCS) Q1 Revenue Rises 15%
Doximity (DOCS) Q1 Revenue Rises 15%
Positive
Zacks Investment Research
1 month ago
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.28 per share a year ago.
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Positive
CNBC
1 month ago
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Doximity has acquired the AI startup Pathway Medical for $63 million.  Pathway has one of the largest structured datasets in medicine, Doximity said.
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Neutral
Business Wire
1 month ago
Doximity Acquires Pathway, a Leader in AI Clinical Reference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway's team. Over the past seven years, they've assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across al.
Doximity Acquires Pathway, a Leader in AI Clinical Reference
Neutral
Business Wire
1 month ago
Doximity Announces Fiscal 2026 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. “We began our year with strong profit growth and record engagement across our newsfeed, workflow, and AI products,” said Jeff Tangney, co-founder and CEO of Doximity. “Our AI suite once again grew the fastest, up 5x year-over-year, while more than 630,000 prescribers used our workflow tools to save.
Doximity Announces Fiscal 2026 First Quarter Financial Results
Charts implemented using Lightweight Charts™